remain ew see unchang fy guidanc
ep although weaker expect stock
 ep profit beat robust organ sale growth
driven amea latam na also solid top-line
trend driven volum growth given consum pantry-load
posit underli price off-set mix shift multipro importantli
covid-rel demand contribut half organ sale
growth impli underli growth still solid ex-covid
would acceler sequenti prior three
quarter covid demand contribut north america growth
europ growth latin america growth less amea
growth develop market amea mostli benefit pantry-load
howev expect top-line slowdown increment develop
market demand dissip emerg market face disrupt suppli
distribut challeng well macro headwind oil-shock
linger away-from-hom channel includ foodservic vend
school conveni store global busi even at-hom
demand normal less busi away-from-hom
na vs less intern howev believ guidanc look
conserv expect away-from-hom trend improv sequenti
social distanc eas forecast org sale growth
guidanc promot spend also ramp
pull back promot last two week march expect
shift spend back half
lower ep result lower ep estim
reflect lower estim higher market multipl rais
pt continu valu ebitda multipl
number adj ep ahead consensu
mse upsid strong organ sale growth
came ahead streetaccount consensu mse lower
food unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
expect sg support profit beat vs consensu organ
sale growth driven notabl intern region
north america org sale vs europ latam amea
 organ sale driven volum growth heighten
consum demand covid gross margin came roughli line
consensu lower expect sg support oper profit
beat profit line higher expect incom support
addit cent ep upsid vs mse
consensu mse price strong volum
sale growth driven underli busi growth increas shipment
due demand europ organ sale growth vs
consensu mse due underli momentum bolster
covid latin america organ sale growth strong vs consensu
mse amea vs consensu mse
growth led momentum emerg market particularli nigeria
pantry-load australia new zealand japan south africa
guidanc reiter reiter guidanc sale profit
deliveri shift first half year includ organ sale growth
guidanc y-o-i adjust oper profit declin y-o-i
constant currenc basi driven divestitur keebler busi
partial off-set growth base busi adjust ep declin
y-o-i constant currenc basi base result
ep rang free cash flow rang also expect
cash oper activ capit expenditur
valuat fair given organ top-line improv off-set weak prot outlook
pt deriv ev/ebitda roughli line current level
support dcf analysi topline/ebit growth wacc exit
remain rang go forward
covid relat tailwind earli
pantri lling higher reinvest
contribut int growth longer term
lt org sale forecast
middl guidanc
includ futur believ
need continu reinvest
behind busi histor cutback
meet top-line growth goal
slight bp lt margin expans per
year valuat price-to-earnings
pension adjust basi report
price margin headwind
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
apr gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
view descript risk reward theme
expans re-rat
expans bp
volum upsid better market share
trend covid-rel pantri lling
pantry/shelf space price upsid
bp cost save upsid
multipl expand ebitda
organ sale growth
support temporari
covid-rel boost sale
longer term remain line
oper margin contract bp
reinvestment/brand-build expand
ev/ebitda impli
lower price weaker categori volum
lower price weaker categori volum
deterior bp privat label
slow health well pressur
commod inat higher valuat
contract ev/ebitda impli
bp price upsid
bp top-line upsid market share growth
share trend post pack
higher margin expans cost save
relat impact pantry-load
china india
view explan region hierarchi
research highest favor quintil
higher us snack growth
busi innov higher ad spend
higher margin expans greater cost save
moder commod
price pressur us sale
disrupt lower oper prot
growth higher reinvest need cost
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
sale
sell administr expens
sg sale
sale bp chang
earn incom tax
earn loss joint ventur
net incom loss attribut non-control interest
incom continu oper
loss /incom attribut non-controlling interest
prepaid
bridg gaap net incom
adjust reconcil net earn oper cash flow
depr amort
dec inc a/r
dec inc inv
inc dec a/p
net chang wc adjust
net cash provid oper activ
net cash use invest activ
flow provid use financ activ
net inc dec note payabl current
issuanc note payabl lt
reduct note payabl lt
issuanc long-term debt
reduct long-term debt
net cash use financ activ
effect exchang rate
chang cash cash equival
cash equival begin period
cash equival end period
